Laurence Feldmeyer Selected Research

Ichthyosis (Xeroderma)

7/2022

The Fate of Epidermal Tight Junctions in the stratum corneum: Their Involvement in the Regulation of Desquamation and Phenotypic Expression of Certain Skin Conditions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laurence Feldmeyer Research Topics

Disease

6	Neoplasms (Cancer) 01/2021 - 01/2010
4	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2021 - 12/2014
4	Bullous Pemphigoid (Pemphigoid) 01/2020 - 01/2017
3	Skin Diseases (Skin Disease) 07/2022 - 02/2012
3	Acute Generalized Exanthematous Pustulosis 01/2019 - 02/2012
2	Folliculitis (Sycosis) 10/2020 - 02/2012
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2016
2	Exanthema (Rash) 01/2019 - 02/2012
2	Pemphigus (Pemphigus Vulgaris) 01/2018 - 02/2012
2	Neoplasm Metastasis (Metastasis) 01/2018 - 11/2016
2	Acne Vulgaris 01/2015 - 03/2014
2	Stevens-Johnson Syndrome (Lyell's Syndrome) 02/2013 - 12/2011
1	Ichthyosis (Xeroderma) 07/2022
1	Hypotrichosis 07/2022
1	Sclerosing Cholangitis 07/2022
1	Fibrosis (Cirrhosis) 05/2022
1	Localized Scleroderma (Morphea) 05/2022
1	Breast Neoplasms (Breast Cancer) 05/2022
1	Erythema 01/2022
1	Hyperpigmentation 01/2022
1	Hypopigmentation (Hypomelanosis) 01/2022
1	Tinea (Ringworm) 05/2021
1	Dermatomycoses 05/2021
1	Candidiasis (Moniliasis) 05/2021
1	Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis) 03/2021
1	Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis) 03/2021
1	Communicable Diseases (Infectious Diseases) 03/2021
1	Pyoderma Gangrenosum 03/2021
1	Hematologic Neoplasms (Hematological Malignancy) 03/2021
1	VEXAS syndrome 01/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2021
1	Eosinophilia 01/2021
1	Muscular Diseases (Myopathy) 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021
1	Rare Diseases (Rare Disease) 01/2021
1	Siderosis 05/2020
1	Iron Deficiencies 05/2020
1	Lichen Sclerosus et Atrophicus (Lichen Sclerosus) 01/2020
1	Inflammation (Inflammations) 01/2019
1	Pityriasis Rubra Pilaris 04/2017
1	Merkel Cell Carcinoma 11/2016
1	Keratoacanthoma familial 09/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2016
1	Infections 07/2016
1	Papillary Adenocarcinoma 01/2016
1	Hutchinson's Melanotic Freckle (Lentigo Maligna) 01/2016
1	Autoimmune Diseases (Autoimmune Disease) 12/2014
1	Skin Neoplasms (Skin Cancer) 11/2013
1	Drug Hypersensitivity (Drug Allergy) 04/2013
1	Familial Mediterranean Fever (Periodic Disease) 04/2012
1	autosomal dominant familial Periodic fever 04/2012

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 01/2021 - 02/2012
3	CytokinesIBA 01/2021 - 01/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2021 - 03/2021
2	Interleukin-17 (Interleukin 17)IBA 05/2021 - 01/2015
2	Colchicine FDA LinkGeneric 03/2021 - 04/2012
2	Immunoglobulin A (IgA)IBA 03/2021 - 02/2012
2	InflammasomesIBA 01/2021 - 03/2014
2	Omalizumab (Xolair)FDA Link 01/2020 - 01/2019
2	Dipeptidyl-Peptidase IV InhibitorsIBA 06/2018 - 01/2017
2	Messenger RNA (mRNA)IBA 04/2017 - 03/2014
2	Imiquimod (Aldara)FDA LinkGeneric 09/2016 - 09/2011
2	Antimicrobial PeptidesIBA 03/2015 - 12/2014
2	AutoantigensIBA 03/2015 - 12/2014
2	Intravenous Immunoglobulins (IVIG)FDA Link 12/2011 - 09/2010
1	Claudin-1IBA 07/2022
1	ixekizumabIBA 05/2021
1	diazonaphthalenedisulfonic acid (NDS)IBA 03/2021
1	Dapsone FDA Link 03/2021
1	AntibodiesIBA 01/2021
1	EnzymesIBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	apremilastIBA 10/2020
1	ferric carboxymaltoseIBA 05/2020
1	IronIBA 05/2020
1	NivolumabIBA 01/2020
1	IpilimumabIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	dupilumabIBA 01/2020
1	Immunoglobulin E (IgE)IBA 01/2019
1	Rituximab (Mabthera)FDA Link 01/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2018
1	Hematoxylin (Haematoxylon)IBA 01/2018
1	Ustekinumab (CNTO 1275)FDA Link 04/2017
1	InterleukinsIBA 04/2017
1	Biomarkers (Surrogate Marker)IBA 11/2016
1	Indicators and Reagents (Reagents)IBA 11/2016
1	SteroidsIBA 07/2016
1	3-ingenyl angelateIBA 01/2016
1	Chemokine ReceptorsIBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 01/2015
1	Adenosine Monophosphate (AMP)IBA 12/2014
1	Biological ProductsIBA 08/2013
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2013

Therapy/Procedure

11	Therapeutics 01/2022 - 09/2011
3	Radiotherapy 05/2022 - 01/2016
1	Biological Therapy 03/2021
1	Lasers (Laser) 05/2020
1	Surgical Amputation (Amputations) 01/2016
1	Transplantation 11/2013